EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
27 hedge funds and large institutions have $37.6M invested in Eagle Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.76M | |
| 2 | +$3.04M | |
| 3 | +$1.68M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$719K |
| 5 |
D.E. Shaw & Co
New York
|
+$447K |
Top Sellers
| 1 | -$444K | |
| 2 | -$217K | |
| 3 | -$206K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$173K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$142K |